Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

FGFR overexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related biomarkers:

‹

FGFR mutation + PD-L1 expression (1)

FGFR mutation + PD-L1 expression (1)

›

FGFR overexpression	Urothelial Cancer	FGFR overexpression	Urothelial Cancer	BAY 1163877 Sensitive: C3 – Early Trials BAY 1163877 Sensitive : C3	BAY 1163877 Sensitive: C3 – Early Trials BAY 1163877 Sensitive : C3
FGFR overexpression	Non Small Cell Lung Cancer	FGFR overexpression	Non Small Cell Lung Cancer	BAY 1163877 Sensitive: C3 – Early Trials BAY 1163877 Sensitive : C3	BAY 1163877 Sensitive: C3 – Early Trials BAY 1163877 Sensitive : C3
FGFR overexpression	Squamous Cell Carcinoma of Head and Neck	FGFR overexpression	Squamous Cell Carcinoma of Head and Neck	BAY 1163877 Sensitive: C3 – Early Trials BAY 1163877 Sensitive : C3	BAY 1163877 Sensitive: C3 – Early Trials BAY 1163877 Sensitive : C3
FGFR overexpression	Lung Cancer	FGFR overexpression	Lung Cancer	ARQ 087 Sensitive: D – Preclinical ARQ 087 Sensitive : D	ARQ 087 Sensitive: D – Preclinical ARQ 087 Sensitive : D
FGFR overexpression	Hepatocellular Cancer	FGFR overexpression	Hepatocellular Cancer	WXSH0011 Sensitive: D – Preclinical WXSH0011 Sensitive : D	WXSH0011 Sensitive: D – Preclinical WXSH0011 Sensitive : D
FGFR overexpression	Urothelial Cancer	FGFR overexpression	Urothelial Cancer	ARQ 087 Sensitive: D – Preclinical ARQ 087 Sensitive : D	ARQ 087 Sensitive: D – Preclinical ARQ 087 Sensitive : D
FGFR overexpression	Gastric Cancer	FGFR overexpression	Gastric Cancer	WXSH0011 Sensitive: D – Preclinical WXSH0011 Sensitive : D	WXSH0011 Sensitive: D – Preclinical WXSH0011 Sensitive : D